Wei Xu

Wei Xu


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 January 2013 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
XJXiu‐Li Jin
Xiu‐Li Jin
QSQin‐Sheng Sun
Qin‐Sheng Sun
FLFeng Liu
Feng Liu
HYHong‐Wei Yang
Hong‐Wei Yang
MLMin Liu
Min Liu
YJYuyang Jiang
Yuyang Jiang

1 June 2014 in Food Chemistry
Verified
Journal Article
Closed access
BWBotao Wang
Botao Wang
JHJunjie Han
Junjie Han
WXWei Xu
Wei Xu
YCYuhui Chen
Yuhui Chen
Hongwei LiuHongwei Liu
Hongwei Liu

Verified
Journal Article
Open access
PDF file
SHShengnan He
Shengnan He
FLFeng Liu
Feng Liu
ZXZhenhua Xie
Zhenhua Xie
XZXuyu Zu
Xuyu Zu
WXWei Xu
Wei Xu
YJYuyang Jiang
Yuyang Jiang
P-glycoprotein (Pgp), encoded by the multidrug resistance 1 (MDR1) gene, is an efflux transporter and plays an important role in pharmacokinetics. In this study, we demonstrated that the pokemon promoter activity, the pokemon mRNA and protein expression can be significantly inhibited by Pgp. Chromatin immunoprecipitation assay showed that Pgp can bind the pokemon prompter to repress pokemon transcription activity. Furthermore, Pgp regulated pokemon transcription activity through expression of p53 as seen by use of p53 siRNA transfected MCF-7 cells or p53 mutated MDA-MB-231 cells. Moreover, p53 was detected to bind with Pgp in vivo using immunoprecipitation assay. Taken together, we conclude that Pgp can regulate the expression of pokemon through the presence of p53, suggesting that Pgp is a potent regulator and may offer an effective novel target for cancer therapy.

1 January 2009 in Journal of Biotechnology
Verified
Journal Article
Closed access
ZMZhuohua Mo
Zhuohua Mo
XZXuyu Zu
Xuyu Zu
ZXZhenhua Xie
Zhenhua Xie
WLWenpeng Li
Wenpeng Li
HNHang Ning
Hang Ning
WXWei Xu
Wei Xu

1 January 2009 in BMC Research Notes
Verified
Journal Article
Open access
PDF file
XZXuyu Zu
Xuyu Zu
LYLingling Yu
Lingling Yu
QSQinsheng Sun
Qinsheng Sun
FLFeng Liu
Feng Liu
JWJue Wang
Jue Wang
YJYuyang Jiang
Yuyang Jiang
Zbtb7A is a proto-oncogenic transcriptional regulator that plays an important role in adipogenesis, osteogenesis and oncogenesis, but little is known about the regulation of Zbtb7A gene expression which is of importance in the function uncovering of this gene.

13 March 2020 in Molecules
Verified
Journal Article
Open access
PDF file
DCDong Cai
Dong Cai
TLTai Li
Tai Li
XQXie Qian
Xie Qian
XYxiaofei yu
xiaofei yu
WXWei Xu
Wei Xu
CHChun Hu
Chun Hu
A series of novel 7-oxo-7H-thiazolo[3,2-b]-1,2,4-triazine-2-carboxylic acid derivatives was synthesized in good yields by a multi-step procedure that included the generation of the S-alkylated derivatives from 6-substituted arylmethyl-3-mercapto-1,2,4-triazin-5-ones with ethyl 2-chloroacetoacetate, intramolecular cyclization with microwave irradiation, hydrolysis and amidation. All of the target compounds were fully characterized through 1H-NMR, 13C-NMR and HRMS spectra. The intramolecular cyclization occurred regioselectively at the N2-position of 1,2,4-triazine ring, which was confirmed by compound 3e using single-crystal X-ray diffraction analysis. The antibacterial and antitubercular activities of the target compounds were evaluated. Compared with Ciprofloxacin and Rifampicin, compounds 5d, 5f and 5g containing the terminal amide fragment exhibited broad spectrum antibacterial activity, and carboxylic acid derivatives or its corresponding ethyl esters had less effect on antibacterial properties. The most potent compound 5f also displayed excellent in vitro antitubercular activity against Mycobacterium smegmatis (minimum inhibitory concentration (MIC) = 50 μg/mL) and better growth inhibition activity of leucyl-tRNA synthetase (78.24 ± 4.05% at 15 μg/mL).